Search and filter adverse-event reports.
1,929,324 reports(833 ms)
Near Drowning; This 11-month-old male subject was enrolled in a blinded study. The subject received the 3rd dose of Bexsero vs Placebo (intramuscular) on 14th May 2019, for prophylaxis. The subject received the 3rd dose of DTPa-HBV-IPV (intramuscular) on 14th…
Tonsillitis; This 15-month-old female subject was enrolled in a blinded study. The subject received the 4th dose of Bexsero vs Placebo co-administered with PCV and routine vaccines (intramuscular) on 28th June 2019. The subject received the 3rd dose of DTPa-HB…
New Onset Type 1 Diabetes Mellitus; DKA (Diabetic Keto Acidosis; This 19-month-old male subject was enrolled in a blinded study. The subject received the 4th dose of Bexsero vs Placebo (intramuscular) on 13th August 2019, for prophylaxis. The subject received…
Urinary Tract Infection; This 9-month-old female subject was enrolled in a blinded study. The subject received the 3rd dose of Bexsero vs Placebo (intramuscular) on 06-APR-2020, for prophylaxis. The subject received the 3rd dose of DTPa-HBV-IPV (intramuscular)…
Seizure; This 11-month-old female subject was enrolled in a blinded study titled. The subject received the 3rd dose of Bexsero vs Placebo (intramuscular) on 02-MAY-2019, for prophylaxis. The subject received the 3rd dose of DTPa-HBV-IPV (intramuscular) on 02-M…
ASTHMA, UNSPECIFIED WITH ACUTE EXACERBATION; This 2-year-old male subject was enrolled in a blinded study. The subject received the 4th dose of Bexsero vs Placebo (intramuscular, right thigh) on 07-OCT-2020, for prophylaxis. The subject received the 3rd dose o…
adenovirus infection; This 6-month-old male subject was enrolled in a blinded study. The subject received the 3rd dose of Bexsero vs Placebo (intramuscular, right thigh) on 29-NOV-2022, for prophylaxis. The subject received the 3rd dose of DTPa-HBV-IPV (intram…
Acute Hypoxic Respiratory Failure; Respiratory Syncytial Virus Bronchiolitis; Disease caused by 2019 Novel Coronavirus; This 7-month-old male subject was enrolled in a blinded study. The subject received the 3rd dose of Bexsero vs Placebo (intramuscular, right…
Bronchiolitis; This 13-month-old female subject was enrolled in a blinded study. The subject received the 4th dose of Bexsero vs Placebo (intramuscular, right thigh) on 13-APR-2023, for prophylaxis. The subject received the 2nd dose of Rotarix lyophilized form…
Coxsackie A16 virus; Influenza B virus; This 18-month-old female subject was enrolled in a blinded study. The subject received the 4th dose of Bexsero vs Placebo (intramuscular, right thigh) on 13-APR-2023. The subject received the 3rd dose of DTPa-HBV-IPV (in…
Gastroenteritis; This 14-month-old male subject was enrolled in a blinded study. The subject received the 3rd dose of Bexsero vs Placebo (intramuscular, right thigh) on 10-OCT-2023, for prophylaxis. The subject received the 3rd dose of Prevnar 13 (intramuscula…
temperature excursion of ipol; max/low temperature reached: 46.7 f (8. 2 c)for 20 minutes, which was administered post excursion with no reported adverse event; Initial information received on 13-Mar-2025 regarding an unsolicited valid non-serious case receiv…
Viral Syndrome; Reactive Airway Disease Exacerbation; Reactive Airway Disease Exacerbation; This 15-month-old female subject was enrolled in a blinded study. The subject received the 4th dose of Bexsero vs Placebo (intramuscular, right thigh) on 18-OCT-2019, f…
Respiratory Syncytial Virus Infection; This 5-month-old male subject was enrolled in a blinded study. The subject received the 2nd dose of Bexsero vs Placebo (intramuscular) on 31st October 2018, for prophylaxis. The subject received the 2nd dose of Prevnar 13…
Respiratory syncytial virus; This 5-month-old male subject was enrolled in a blinded study. The subject received the 2nd dose of Bexsero vs Placebo (intramuscular) on 13th December 2018, for prophylaxis. The subject received the 2nd dose of Prevnar 13 (intramu…
Respiratory Syncytial Virus bronchiolitis; This 4-month-old female subject was enrolled in a blinded study. The subject received the 2nd dose of Bexsero vs Placebo (intramuscular) on 4th December 2018, for prophylaxis. The subject received the 2nd dose of Prev…
RSV bronchiolitis; This 4-month-old male subject was enrolled in a blinded study. The subject received the 2nd dose of Bexsero vs Placebo (intramuscular) on 17-JAN-2019, for prophylaxis. The subject received the 2nd dose of DTPa-HBV-IPV (intramuscular, left th…
Urinary Tract Infection; Respiratory Viral Syndrome; This 3-month-old female subject was enrolled in a blinded study. The subject received the 1st dose of Bexsero vs Placebo (intramuscular, right thigh) on 04-JAN-2019, for prophylaxis. The subject received the…
Lower Respiratory Tract Infection (LRTI); Upper Respiratory Infection (URI); This 9-month-old male subject was enrolled in a blinded study. The subject received the 3rd dose of Bexsero vs Placebo co-administered with PCV and routine vaccines (intramuscular, le…
Bronchiolitis; dehydration; Influenza-Like Illness; This 6-month-old female subject was enrolled in a blinded study. The subject received the 2nd dose of Bexsero vs Placebo (intramuscular) on 22nd August 2019, for prophylaxis. The subject received the 2nd dose…